GUARDANT HEALTH, INC. Stock-Based Compensation
GUARDANT HEALTH, INC. (GH) reported Stock-Based Compensation of $105.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $57.73M, a 35.95% increase year-over-year.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $47.61M, a 26.09% increase year-over-year.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $43.19M, a 18.76% increase year-over-year.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $42.81M, a 13.99% decline year-over-year.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $166.22M, a 18.38% increase from fiscal 2024.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $140.41M, a 54.71% increase from fiscal 2023.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $90.76M, a 4.15% decline from fiscal 2022.
- GUARDANT HEALTH, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $94.69M, a 37.48% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $57.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $105.33M 10-Q · filed 2026-07-30 | $148.52M derived: sum of 3 quarters · filed 2026-07-30 | $191.33M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $47.61M 10-Q · filed 2026-05-07 | $90.80M derived: sum of 2 quarters · filed 2026-05-07 | $133.61M derived: sum of 3 quarters · filed 2026-05-07 | $176.07M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $43.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $86.00M derived: sum of 2 quarters · filed 2026-02-19 | $128.46M derived: sum of 3 quarters · filed 2026-07-30 | $166.22M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $42.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $85.27M derived: sum of 2 quarters · filed 2026-07-30 | $123.03M 10-Q · filed 2025-10-29 | $159.39M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $42.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $80.22M 10-Q · filed 2026-07-30 | $116.58M derived: sum of 3 quarters · filed 2026-07-30 | $166.35M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $37.76M 10-Q · filed 2026-05-07 | $74.12M derived: sum of 2 quarters · filed 2026-05-07 | $123.89M derived: sum of 3 quarters · filed 2026-05-07 | $151.13M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $36.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $86.14M derived: sum of 2 quarters · filed 2026-02-19 | $113.37M derived: sum of 3 quarters · filed 2026-02-19 | $140.41M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $49.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $77.00M derived: sum of 2 quarters · filed 2025-10-29 | $104.05M 10-Q · filed 2025-10-29 | $128.37M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | $27.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $54.28M 10-Q · filed 2025-07-30 | $78.60M derived: sum of 3 quarters · filed 2026-02-19 | $100.42M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | $27.04M 10-Q · filed 2025-04-30 | $51.36M derived: sum of 2 quarters · filed 2026-02-19 | $73.18M derived: sum of 3 quarters · filed 2026-02-19 | $95.53M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | $24.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $46.14M derived: sum of 2 quarters · filed 2026-02-19 | $68.49M derived: sum of 3 quarters · filed 2026-02-19 | $90.76M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $21.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $44.17M derived: sum of 2 quarters · filed 2024-11-06 | $66.44M 10-Q · filed 2024-11-06 | $90.14M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | $22.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $44.62M 10-Q · filed 2024-08-07 | $68.32M derived: sum of 3 quarters · filed 2025-02-20 | $88.96M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | $22.27M 10-Q · filed 2024-05-09 | $45.97M derived: sum of 2 quarters · filed 2025-02-20 | $66.61M derived: sum of 3 quarters · filed 2025-02-20 | $92.15M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $23.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $44.34M derived: sum of 2 quarters · filed 2025-02-20 | $69.89M derived: sum of 3 quarters · filed 2025-02-20 | $94.69M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $20.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $46.18M derived: sum of 2 quarters · filed 2023-11-06 | $70.98M 10-Q · filed 2023-11-06 | $97.84M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | $25.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $50.34M 10-Q · filed 2023-08-03 | $77.20M derived: sum of 3 quarters · filed 2024-02-22 | $112.22M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $24.80M 10-Q · filed 2023-05-09 | $51.66M derived: sum of 2 quarters · filed 2024-02-22 | $86.67M derived: sum of 3 quarters · filed 2024-02-22 | $121.18M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $26.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $61.87M derived: sum of 2 quarters · filed 2024-02-22 | $96.38M derived: sum of 3 quarters · filed 2024-02-22 | $151.45M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $35.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $69.52M derived: sum of 2 quarters · filed 2022-11-03 | $124.59M 10-Q · filed 2022-11-03 | $181.35M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $34.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $89.58M 10-Q · filed 2022-08-04 | $146.34M derived: sum of 3 quarters · filed 2023-02-23 | $201.54M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $55.07M 10-Q · filed 2022-05-05 | $111.83M derived: sum of 2 quarters · filed 2023-02-23 | $167.03M derived: sum of 3 quarters · filed 2023-02-23 | $192.84M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $56.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $111.96M derived: sum of 2 quarters · filed 2023-02-23 | $137.78M derived: sum of 3 quarters · filed 2023-02-23 | $144.11M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $55.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $81.01M derived: sum of 2 quarters · filed 2021-11-04 | $87.35M 10-Q · filed 2021-11-04 | $92.42M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $25.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $32.15M 10-Q · filed 2021-08-05 | $37.23M derived: sum of 3 quarters · filed 2022-02-24 | $42.71M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $6.34M 10-Q · filed 2021-05-06 | $11.41M derived: sum of 2 quarters · filed 2022-02-24 | $16.89M derived: sum of 3 quarters · filed 2022-02-24 | $20.11M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.56M derived: sum of 2 quarters · filed 2022-02-24 | $13.77M derived: sum of 3 quarters · filed 2022-02-24 | $16.95M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.70M derived: sum of 2 quarters · filed 2020-11-05 | $11.88M 10-Q · filed 2020-11-05 | $14.45M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $6.40M 10-Q · filed 2020-08-06 | $6.40M 10-Q · filed 2019-08-07 | $8.96M derived: sum of 3 quarters · filed 2021-02-25 | $10.79M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $3.18M 10-Q · filed 2020-05-07 | $5.75M derived: sum of 2 quarters · filed 2021-02-25 | $7.58M derived: sum of 3 quarters · filed 2021-02-25 | $8.76M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.39M derived: sum of 2 quarters · filed 2021-02-25 | $5.57M derived: sum of 3 quarters · filed 2021-02-25 | $6.85M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.01M derived: sum of 2 quarters · filed 2019-11-07 | $4.29M 10-Q · filed 2019-11-07 | $5.86M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.46M 10-Q · filed 2019-08-07 | $4.03M derived: sum of 3 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $1.28M 10-Q · filed 2019-05-10 | $2.85M derived: sum of 2 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.67M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $2.10M 10-Q · filed 2018-11-19 | ||||
| 2016-12-31 | $1.97M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |